Metraipolis › archive › dc_bf85f9da14be

Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report — Europe PMC PMID:41393637

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41393637
DOI
10.7759/cureus.96555
License (as archived)
solo-consultazione
Archived
2026-11-08T16:02:13.028Z
SHA-256 of the archived text
224e5575ea94c40196a56f50b0657daed6e2ede9b47b5d23736bd55ee7decf70
Stable URL of this page
https://metraipolis.com/documento/dc_bf85f9da14be

How to cite

Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report — Europe PMC PMID:41393637 — Europe PMC (en), https://europepmc.org/article/MED/41393637 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf85f9da14be (Metraipolis archive dc_bf85f9da14be, sha256 224e5575ea94c40196a56f50b0657daed6e2ede9b47b5d23736bd55ee7decf70)
BibTeX
@misc{dcbf85f9da14be,
  title = {Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report — Europe PMC PMID:41393637},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41393637},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf85f9da14be; sha256 224e5575ea94c40196a56f50b0657daed6e2ede9b47b5d23736bd55ee7decf70},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41393637. Agents can read the archived copy with the MCP tool read_document.